Recently, the expression of TNFAIP8 family has been reported to be altered in the development of many types of cancers, including HCC, intestinal-type gastric adenocarcinoma, lung cancer, epithelial ovarian cancer, endometrial cancer and colon cancer [13–18]. Here, TNFAIP8 is linked to hepatocellular carcinoma.